Matches in Ubergraph for { <https://frink.apps.renci.org/.well-known/genid/B5e63e1ac0136e461b2816fddba3b253e> ?p ?o ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- B5e63e1ac0136e461b2816fddba3b253e NCIT_P378 "NCI" @default.
- B5e63e1ac0136e461b2816fddba3b253e type Axiom @default.
- B5e63e1ac0136e461b2816fddba3b253e annotatedProperty IAO_0000115 @default.
- B5e63e1ac0136e461b2816fddba3b253e annotatedSource NCIT_C157488 @default.
- B5e63e1ac0136e461b2816fddba3b253e annotatedTarget "A preparation of autologous cytotoxic T-lymphocytes (CTLs) that are specifically reactive to Epstein-Barr virus (EBV) latent membrane protein-2A (LMP-2A) and expressing the co-stimulatory domain 4-1BB (CD137), with potential antineoplastic activity. Upon administration of the EBV/LMP-2A-specific autologous CD8+ T-cells to patients with EBV-positive tumors, these cells bind to and cause cell death in EBV-infected cells. This inhibits proliferation of EBV LMP-2A-expressing tumor cells. EBV LMP-2A is expressed in various malignancies and plays a key role in tumor cell proliferation and survival. 4-1BB, an inducible costimulatory member of the tumor-necrosis factor receptor (TNFR) family, is expressed on activated T-cells. It activates additional CD8+ T-cells, prevents activation-induced cell death of CD8+ T-cells, and selectively induces T-helper 1 (Th1)-type cytokines such as interferon (IFN)-gamma and tumor-necrosis factor-alpha (TNF-alpha)." @default.